Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
8-week oral pentaerithrityl tetranitrate in stable coronary artery disease
2006-004533-15Phase 4Active
- Sponsor
- II. Medizinische Klinik, Universitätsmedizin Mainz
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of pentaerythrityl tetranitrate in coronary arteriosclerosis and stable angina, sponsored by II. Medizinische Klinik, Universitätsmedizin Mainz. Primary endpoint: Absolute change in flow-mediated vasodilation. Started Aug 2007; status: active.
02
Drugs
pentaerythrityl tetranitrate
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on 2006-004533-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004533-15.